328 related articles for article (PubMed ID: 19304573)
1. Chylomicronemia with a mutant GPIHBP1 (Q115P) that cannot bind lipoprotein lipase.
Beigneux AP; Franssen R; Bensadoun A; Gin P; Melford K; Peter J; Walzem RL; Weinstein MM; Davies BS; Kuivenhoven JA; Kastelein JJ; Fong LG; Dallinga-Thie GM; Young SG
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):956-62. PubMed ID: 19304573
[TBL] [Abstract][Full Text] [Related]
2. Chylomicronemia with low postheparin lipoprotein lipase levels in the setting of GPIHBP1 defects.
Franssen R; Young SG; Peelman F; Hertecant J; Sierts JA; Schimmel AW; Bensadoun A; Kastelein JJ; Fong LG; Dallinga-Thie GM; Beigneux AP
Circ Cardiovasc Genet; 2010 Apr; 3(2):169-78. PubMed ID: 20124439
[TBL] [Abstract][Full Text] [Related]
3. GPIHBP1 missense mutations often cause multimerization of GPIHBP1 and thereby prevent lipoprotein lipase binding.
Beigneux AP; Fong LG; Bensadoun A; Davies BS; Oberer M; Gårdsvoll H; Ploug M; Young SG
Circ Res; 2015 Feb; 116(4):624-32. PubMed ID: 25387803
[TBL] [Abstract][Full Text] [Related]
4. Mutations in lipoprotein lipase that block binding to the endothelial cell transporter GPIHBP1.
Voss CV; Davies BS; Tat S; Gin P; Fong LG; Pelletier C; Mottler CD; Bensadoun A; Beigneux AP; Young SG
Proc Natl Acad Sci U S A; 2011 May; 108(19):7980-4. PubMed ID: 21518912
[TBL] [Abstract][Full Text] [Related]
5. GPIHBP1 C89F neomutation and hydrophobic C-terminal domain G175R mutation in two pedigrees with severe hyperchylomicronemia.
Charrière S; Peretti N; Bernard S; Di Filippo M; Sassolas A; Merlin M; Delay M; Debard C; Lefai E; Lachaux A; Moulin P; Marçais C
J Clin Endocrinol Metab; 2011 Oct; 96(10):E1675-9. PubMed ID: 21816778
[TBL] [Abstract][Full Text] [Related]
6. Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.
Gin P; Beigneux AP; Davies B; Young MF; Ryan RO; Bensadoun A; Fong LG; Young SG
Biochim Biophys Acta; 2007 Dec; 1771(12):1464-8. PubMed ID: 17997385
[TBL] [Abstract][Full Text] [Related]
7. Mutation of conserved cysteines in the Ly6 domain of GPIHBP1 in familial chylomicronemia.
Olivecrona G; Ehrenborg E; Semb H; Makoveichuk E; Lindberg A; Hayden MR; Gin P; Davies BS; Weinstein MM; Fong LG; Beigneux AP; Young SG; Olivecrona T; Hernell O
J Lipid Res; 2010 Jun; 51(6):1535-45. PubMed ID: 20026666
[TBL] [Abstract][Full Text] [Related]
8. Multimerization of glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1 (GPIHBP1) and familial chylomicronemia from a serine-to-cysteine substitution in GPIHBP1 Ly6 domain.
Plengpanich W; Young SG; Khovidhunkit W; Bensadoun A; Karnman H; Ploug M; Gårdsvoll H; Leung CS; Adeyo O; Larsson M; Muanpetch S; Charoen S; Fong LG; Niramitmahapanya S; Beigneux AP
J Biol Chem; 2014 Jul; 289(28):19491-9. PubMed ID: 24847059
[TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of three known and one novel LPL variants in patients with type I hyperlipoproteinemia.
Caddeo A; Mancina RM; Pirazzi C; Russo C; Sasidharan K; Sandstedt J; Maurotti S; Montalcini T; Pujia A; Leren TP; Romeo S; Pingitore P
Nutr Metab Cardiovasc Dis; 2018 Feb; 28(2):158-164. PubMed ID: 29288010
[TBL] [Abstract][Full Text] [Related]
10. Some things just have to be done in vivo: GPIHBP1, caloric delivery, and the generation of remnant lipoproteins.
Williams KJ
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):792-5. PubMed ID: 19458350
[TBL] [Abstract][Full Text] [Related]
11. GPIHBP1, an endothelial cell transporter for lipoprotein lipase.
Young SG; Davies BS; Voss CV; Gin P; Weinstein MM; Tontonoz P; Reue K; Bensadoun A; Fong LG; Beigneux AP
J Lipid Res; 2011 Nov; 52(11):1869-84. PubMed ID: 21844202
[TBL] [Abstract][Full Text] [Related]
12. Homozygous missense mutation (G56R) in glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPI-HBP1) in two siblings with fasting chylomicronemia (MIM 144650).
Wang J; Hegele RA
Lipids Health Dis; 2007 Sep; 6():23. PubMed ID: 17883852
[TBL] [Abstract][Full Text] [Related]
13. Clinical and genetic features of 3 patients with familial chylomicronemia due to mutations in GPIHBP1 gene.
Rabacchi C; D'Addato S; Palmisano S; Lucchi T; Bertolini S; Calandra S; Tarugi P
J Clin Lipidol; 2016; 10(4):915-921.e4. PubMed ID: 27578123
[TBL] [Abstract][Full Text] [Related]
14. Binding preferences for GPIHBP1, a glycosylphosphatidylinositol-anchored protein of capillary endothelial cells.
Gin P; Beigneux AP; Voss C; Davies BS; Beckstead JA; Ryan RO; Bensadoun A; Fong LG; Young SG
Arterioscler Thromb Vasc Biol; 2011 Jan; 31(1):176-82. PubMed ID: 20966398
[TBL] [Abstract][Full Text] [Related]
15. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia.
Hu X; Dallinga-Thie GM; Hovingh GK; Chang SY; Sandoval NP; Dang TLP; Fukamachi I; Miyashita K; Nakajima K; Murakami M; Fong LG; Ploug M; Young SG; Beigneux AP
J Clin Lipidol; 2017; 11(4):964-971. PubMed ID: 28666713
[TBL] [Abstract][Full Text] [Related]
16. Mutating a conserved cysteine in GPIHBP1 reduces amounts of GPIHBP1 in capillaries and abolishes LPL binding.
Allan CM; Jung CJ; Larsson M; Heizer PJ; Tu Y; Sandoval NP; Dang TLP; Jung RS; Beigneux AP; de Jong PJ; Fong LG; Young SG
J Lipid Res; 2017 Jul; 58(7):1453-1461. PubMed ID: 28476858
[TBL] [Abstract][Full Text] [Related]
17. Incidental finding of severe hypertriglyceridemia in children. Role of multiple rare variants in genes affecting plasma triglyceride.
Buonuomo PS; Rabacchi C; Macchiaiolo M; Trenti C; Fasano T; Tarugi P; Bartuli A; Bertolini S; Calandra S
J Clin Lipidol; 2017; 11(6):1329-1337.e3. PubMed ID: 28951076
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies against GPIHBP1 as a Cause of Hypertriglyceridemia.
Beigneux AP; Miyashita K; Ploug M; Blom DJ; Ai M; Linton MF; Khovidhunkit W; Dufour R; Garg A; McMahon MA; Pullinger CR; Sandoval NP; Hu X; Allan CM; Larsson M; Machida T; Murakami M; Reue K; Tontonoz P; Goldberg IJ; Moulin P; Charrière S; Fong LG; Nakajima K; Young SG
N Engl J Med; 2017 Apr; 376(17):1647-1658. PubMed ID: 28402248
[TBL] [Abstract][Full Text] [Related]
19. Chylomicronemia mutations yield new insights into interactions between lipoprotein lipase and GPIHBP1.
Gin P; Goulbourne CN; Adeyo O; Beigneux AP; Davies BS; Tat S; Voss CV; Bensadoun A; Fong LG; Young SG
Hum Mol Genet; 2012 Jul; 21(13):2961-72. PubMed ID: 22493000
[TBL] [Abstract][Full Text] [Related]
20. Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins.
Adeyo O; Goulbourne CN; Bensadoun A; Beigneux AP; Fong LG; Young SG
J Intern Med; 2012 Dec; 272(6):528-40. PubMed ID: 23020258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]